aiGENE is a universal blood test that measures cancer and cancer therapy efficacy.
aiGENE has raised $250K in total funding. The most recent round was Grant. The last funding was announced in May 2023.
aiGENE's investors include Advanced Industries Accelerator (AIA) Program.
aiGENE is headquartered in Aurora, United States.
aiGENE is a universal blood test that measures cancer and cancer therapy efficacy.
aiGENE is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"aiGENE — Funding & Investors." VCBacked, May 18, 2023, https://www.vcbacked.co/company/aigene. Accessed July 24, 2026.
VCBacked. (2023). aiGENE — Funding & Investors. Retrieved July 24, 2026, from https://www.vcbacked.co/company/aigene
{{cite web |title=aiGENE — Funding & Investors |url=https://www.vcbacked.co/company/aigene |website=VCBacked |access-date=July 24, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated